Measles Making a Comeback in the U.S.
Par Rédaction Flash Radio | | Catégorie : International

The U.S., once in control of measles, is seeing the disease resurface after decades of efforts. With cases on the rise and vaccination coverage declining, the country is losing its status as measles-f
The U.S., once in control of measles, is seeing the disease resurface after decades of efforts. With cases on the rise and vaccination coverage declining, the country is losing its status as measles-free. Yahia Mekki, virologist at the CHU of Lyon, reveals the public health challenges and risks. ⏱️ 1 min read. The facts and recent developments. Since 2000, the U.S. had successfully eradicated measles thanks to an ambitious vaccination program. However, the rise of anti-vax movements and fragmented health policies have weakened this system. In 2019, an epidemic of 1,000 cases already highlighted the system's vulnerability, but corrective measures were insufficient. The current situation reminds us of the risks of a disease that, if not controlled, can spread rapidly, especially in areas with low vaccination coverage. The reappearance of measles in the U.S. has repercussions far beyond its borders. The Mediterranean, which includes Tunisia, remains exposed to imported cases, especially with the growth of international travel. The virologist warns of the importance of strengthening vaccination campaigns, particularly in regions where vaccination rates remain below 90%. In Tunisia, despite efforts, the coverage rate is at 85%, making the population vulnerable to imports. Facing this threat, U.S. authorities are considering intensifying awareness campaigns and increased cooperation with neighboring countries. Yahia Mekki emphasizes that the eradication of measles depends not only on science but also on citizen mobilization and transparency in health policies. ⚡ Key points ▸ The CDC recorded a peak of 200 cases in 2023, compared to 70 in 2022, with vaccination coverage at 90%, below the critical threshold of 95%. ▸ Misinformation and the